Try our beta test site

MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )
ClinicalTrials.gov Identifier:
NCT01633112
First received: June 29, 2012
Last updated: February 6, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 23, 2022
  Estimated Primary Completion Date: March 23, 2022 (Final data collection date for primary outcome measure)